Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rhabdoviridae Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00708084
What this trial is testing

Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents

Who this might be right for
Rabies
Crucell Holland BV 48
Testing effectiveness (Phase 2)Study completedNCT00656097
What this trial is testing

Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

Who this might be right for
Rabies
Crucell Holland BV 140
Large-scale testing (Phase 3)Study completedNCT01388985
What this trial is testing

Simplifying the Rabies Pre-exposure Vaccination

Who this might be right for
Rabies
Institute of Tropical Medicine, Belgium 500
Large-scale testing (Phase 3)UnknownNCT05667974
What this trial is testing

Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

Who this might be right for
RabiesPrevention
Yisheng Biopharma (Singapore) Pte. Ltd. 4,500
Not applicableStudy completedNCT01044199
What this trial is testing

Study of Intradermal Administration of PCEC Rabies Vaccine

Who this might be right for
Rabies PreventionRabies Exposure
Centers for Disease Control and Prevention 130
Testing effectiveness (Phase 2)Study completedNCT02956421
What this trial is testing

Efficacy and Safety of a PIKA Rabies Vaccine Containing the PIKA Adjuvant With an Accelerated Regimen

Who this might be right for
Rabies
Yisheng Biopharma (Singapore) Pte. Ltd. 126
Not applicableLooking for participantsNCT07327307
What this trial is testing

Real World Evidence Study of SYN023 in Children Exposed to Rabies

Who this might be right for
Rabies Post-exposure Prophylaxis
Synermore Biologics (Suzhou) Co., Ltd. 232
Testing effectiveness (Phase 2)Study completedNCT01228383
What this trial is testing

Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults

Who this might be right for
Rabies
Crucell Holland BV 240
Large-scale testing (Phase 3)Active Not RecruitingNCT07275645
What this trial is testing

A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years

Who this might be right for
Rabies
Ab&B Bio-tech Co., Ltd.JS 3,000
Large-scale testing (Phase 3)Study completedNCT01680016
What this trial is testing

A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older Adults

Who this might be right for
Rabies
Novartis Vaccines 644
Large-scale testing (Phase 3)Study completedNCT02491541
What this trial is testing

Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

Who this might be right for
Rabies
Jiangsu Province Centers for Disease Control and Prevention 1,200
Not applicableAvailableNCT07706907
What this trial is testing

An Expanded Access Program for SYN023 in Rabies Treatment

Who this might be right for
Rabies
Synermore Biologics (Suzhou) Co., Ltd.
Post-approval studies (Phase 4)Study completedNCT01365494
What this trial is testing

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

Who this might be right for
Rabies
Novartis Vaccines 250
Post-approval studies (Phase 4)UnknownNCT01173302
What this trial is testing

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Who this might be right for
Rabies
Peking University People's Hospital 160
Not applicableStudy completedNCT07012083
What this trial is testing

Adherence to Anti-rabies Post-exposure Prophylactic Protocols

Who this might be right for
Rabies
Tanta University 214
Not applicableStudy completedNCT01610362
What this trial is testing

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

Who this might be right for
Rabies
Queen Saovabha Memorial Institute 50
Early research (Phase 1)Study completedNCT04062669
What this trial is testing

Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults

Who this might be right for
Virus Diseases
GlaxoSmithKline 160
Large-scale testing (Phase 3)Study completedNCT03965962
What this trial is testing

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults

Who this might be right for
Rabies (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 640
Large-scale testing (Phase 3)Study completedNCT01466387
What this trial is testing

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Who this might be right for
Meningococcal DiseaseMeningococcal MeningitisTyphoid+3 more
Novartis 552
Early research (Phase 1)Study completedNCT04019444
What this trial is testing

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects

Who this might be right for
RabiesRabies Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 50
Next Page